Emcure Pharmaceuticals Limited IPO (Emcure Pharmaceuticals IPO)

Emcure Pharmaceuticals IPO
Upcoming Emcure Pharmaceuticals IPO | New Emcure Pharmaceuticals IPO

Emcure Pharmaceuticals Limited is a leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.

The company has been ranked 13th in domestic sales among pharmaceutical companies in India for MAT September 2023 and 4th in market share in its covered markets for the same period. Additionally, it is the leading pharmaceutical company in gynaecology and HIV antiviral therapeutic areas for the MAT September 2023.

In the six months ended September 30, 2023, and the Financial Year 2023, sales in India contributed 50.84% and 53.16% of the company’s total revenue, respectively. The company’s Domestic sales grew at a CAGR of 10.80% between September 2019 and September 2023, outperforming the Indian pharmaceutical market.

As of September 30, 2023, Emcure Pharma employed 552 scientists and operated five research facilities in India. They filed over 1,800 documents globally, including 204 in the EU and 133 in Canada. They had 201 granted patents, 33 pending patent applications, and submitted 102 drug master files.

Emcure Pharmaceuticals has 13 manufacturing facilities in India. These facilities can produce various pharmaceutical and biopharmaceutical products, including pills, liquids, injectables, and complex ingredients such as chiral molecules, iron molecules, and cytotoxic substances.

As of September 30, 2023, the company’s marketing and distribution network in India was supported by over 5,000 field personnel who regularly interacted with healthcare providers. The distribution network included over 5,000 stockists, served by 37 carry-and-forward agents.

Emcure Pharmaceuticals IPO

Emcure Pharmaceuticals IPO – Details

IPO Opening Date03 July 2024
IPO Closing Date05 July 2024
Issue TypeBook Built Issue IPO
Issue SizeTotal Issue Size: 1,93,65,347 Shares Worth ₹1952.03 Crore
Fresh Issue: 79,36,508 Shares Worth ₹800.00 Crore
Offer For Sale: 1,14,28,839 Shares Worth ₹1152.03 Crore
Face Value₹10 per equity share
IPO Price₹960 – ₹1008 per share
Market Lot14 Shares
Min Order14 Shares (1 Lot)
Employee Discount₹90
Listing AtBSE, NSE
RegisterLink Intime India Private Ltd
QIB Shares Offered50%
NII (HNI) Shares Offered15%
Retail Shares Offered35%

Emcure Pharmaceuticals IPO – Date Schedule

IPO Open Date03 July 2024
IPO Close Date05 July 2024
Credit of Shares to Demat Account08 July 2024
Initiation of Refund09 July 2024
Credit of Shares to Demat Account09 July 2024
IPO Listing Date10 July 2024
Cut-off time for UPI mandate confirmation5 PM on July 05, 2024

Emcure Pharmaceuticals IPO – Lots Size & Price

ApplicationLotsSharesAmount
Retail (Min)114₹14,112
Retail (Max)14196₹1,97,568
S-HNI (Min)15210₹2,11,680
S-HNI (Max)70980₹9,87,840
B-HNI (Min)71994₹10,01,952

Competitive Strengths

  • Well-placed to leverage our position in the domestic market.
  • Demonstrated capabilities of building brands.
  • Large, diversified and fast-growing product portfolio in international markets.
  • Strong R&D capabilities driving differentiated portfolio of products.
  • Extensive and diversified manufacturing capacity.
  • Highly qualified, experienced and entrepreneurial management team and Board.

Company Financials

ParticularsTotal RevenueTotal ExpenseProfit After TaxTotal Borrowing
31 March 20225918.864946.31702.552102.19
31 March 20236031.715278.35561.842202.42
31 March 20246715.245978.08527.572091.93
Amount in ₹ Crore

Key Performance Indicator

KPIValues
ROE16.90%
ROCE19.37%
Debt/Equity0.67
RoNW16.87%
P/BV6.18
Pre IPOPost IPO
EPS (Rs)29.1727.95
P/E (x)34.5536.07

Object Of The Issue

  • Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the company; and
  • General corporate purposes.
Emcure Pharmaceuticals IPO
Object of the Issues

Emcure Pharmaceuticals IPO Peer Comparison

S. No.Face ValueCompany NamePE
110Abbott India Limited47.43
22Alkem Laboratories Limited33.86
31J. B. Chemicals & Pharmaceuticals Limited50.49
42Cipla Limited30.10
55Dr. Reddy’s Laboratories Limited17.93
65Torrent Pharmaceuticals Limited57.74
71Mankind Pharma Limited45.30

Emcure Pharmaceuticals IPO Promoter Holding

Pre Issue Share Holding82.97%
Post Issue Share Holding77.85%

Emcure Pharmaceuticals IPO Prospectus

Company Contact Information

Emcure Pharmaceuticals Limited

Plot No. P-1 and P-2,
IT-BT Park, Phase II, M.I.D.C.,
Hinjawadi, Pune -411 057

Phone: +91 20 3507 0033
Email: investors@emcure.co.in
Websitehttps://www.emcure.com/

Emcure Pharmaceuticals IPO Registrar

Link Intime India Private Ltd

Phone: +91-22-4918 6270
Email: emcure.ipo@linkintime.co.in
Websitehttps://linkintime.co.in/initial_offer/public-issues.html

Emcure Pharmaceuticals IPO Lead Manager(s)

1. Kotak Mahindra Capital Company Limited
2. Axis Capital Limited
3. Jefferies India Private Limited
4. J. P. Morgan India Private Limited

Emcure Pharmaceuticals IPO FAQs

Emcure Pharmaceuticals IPO FAQs
What is Emcure Pharmaceuticals IPO?

Emcure Pharmaceuticals IPO is a main-board IPO. The issue is priced at ₹960 to ₹1008 per equity share. The IPO is to be listed on BSE & NSE.
When Emcure Pharmaceuticals IPO will open?

The IPO is to open on 03 July 2024 for QIB, NII, and Retail Investors.
What is Emcure Pharmaceuticals IPO Investors Portion?

The investors’ portion for QIB – 50%NII – 15%, and Retail – 35%.
How to Apply the Emcure Pharmaceuticals IPO?

You can apply Emcure Pharmaceuticals IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.
How to Apply the Emcure Pharmaceuticals IPO through Angle One?

Log in to Angle One Application with your credentials. Select the IPO. You will see the IPO Name “Emcure Pharmaceuticals”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Angle One.
How to Apply the Emcure Pharmaceuticals IPO through 5 Paisa?

Log in to 5 Paisa Application with your credentials. Select the IPO. You will see the IPO Name “Emcure Pharmaceuticals“. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with 5 Paisa.
How to Apply the Emcure Pharmaceuticals IPO through Upstox?

Log in to Upstox Application with your credentials. Select the IPO. You will see the IPO Name “Emcure Pharmaceuticals”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Upstox.
How to Apply the Emcure Pharmaceuticals IPO through IIFL?

Log in to IIFL Application with your credentials. Select the IPO. You will see the IPO Name “Emcure Pharmaceuticals”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with IIFL.
What is Emcure Pharmaceuticals IPO Size?

Emcure Pharmaceuticals IPO size is ₹1952.03 Crore.
What is Emcure Pharmaceuticals IPO Price Band?

Emcure Pharmaceuticals IPO Price Band is ₹960 to ₹1008.
What is Emcure Pharmaceuticals IPO Minimum and Maximum Lot Size for retail?

The minimum bid is 14 Shares with ₹14,112 amount while the maximum bid is 196 Shares with ₹1,97,568.
What is the Emcure Pharmaceuticals IPO Allotment Date?

Emcure Pharmaceuticals IPO allotment date is 08 July 2024.
What is the Emcure Pharmaceuticals IPO Listing Date?

Emcure Pharmaceuticals IPO listing date is 10 July 2024. The IPO is to be listed on BSE and NSE.
Share Market IPO App
Previous articleNephro Care India Limited IPO (Nephro Care India IPO)
Next articleBansal Wire Industries Limited IPO (Bansal Wire IPO)